Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00706433 · ClinicalTrials.gov registry record · Phase 2
Light Dose Ranging Study of Photodynamic Therapy (PDT) With Levulan + Blue Light Versus Vehicle + Blue Light in Severe Facial Acne
A Phase 2 study of Acne Vulgaris, sponsored by DUSA Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 266
- Enrollment target
- 14
- Study locations
NCT00706433: Completed Phase 2 study of Acne Vulgaris, sponsored by DUSA Pharmaceuticals.
NCT00706433 is a Phase 2 study of Acne Vulgaris that has completed, run by DUSA Pharmaceuticals. The registered enrollment target is 266 participants, roughly in line with the 271-participant average among 67 other Acne Vulgaris trials with a reported enrollment target. The trial reports 14 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00706433, a Phase 2 study of Acne Vulgaris, has completed, sponsored by DUSA Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 266 participants
- Enrollment target
- 14
- Study locations
Study Summary
The purpose of this study is to determine and compare the safety and efficacy of multiple broad area photodynamic therapy treatments with aminolevulinic acid (ALA-PDT) and vehicle (VEH-PDT) in subjects with moderate to severe facial acne vulgaris.
Conditions Studied
Interventions
- DRUG aminolevulinic acid HCL (ALA)
- OTHER Vehicle (VEH)
Study Locations (14)
Texas
- Derm Research Inc - Austin
- Baylor Research Institute - Dallas
Arkansas
- Burke Pharmaceutical Research - Hot Springs
California
- Therapeutics Clinical Research - San Diego
Colorado
- Cherry Creek Research, Inc. - Denver
Florida
- Kenneth R. Beer, M.D. P.A. - West Palm Beach
Georgia
- Gwinnett Clinical Research Center, Inc. - Snellville
Indiana
- Laser and Skin Surger Center of Indiana - Carmel
Kentucky
- Derm Research PLLC - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 266 participants |
| Start Date | 2007-03 |
| Est. Completion | 2008-07 |
| Phase | Phase 2 |
What the finished NCT00706433 record still lists
NCT00706433 is an interventional study that assigns participants to a tested intervention. The registered 266 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 271-participant average among 67 other Acne Vulgaris trials with a reported enrollment target.
The record links to 1 condition, with Acne Vulgaris appearing as the primary indexed condition, and to 2 interventions - of which aminolevulinic acid HCL (ALA) is the first listed.
NCT00706433 lists 14 locations in 13 states (Texas, Arkansas, California).
Frequently Asked Questions
What is clinical trial NCT00706433 about?
NCT00706433 is a clinical study titled "Light Dose Ranging Study of Photodynamic Therapy (PDT) With Levulan + Blue Light Versus Vehicle + Blue Light in Severe Facial Acne". The purpose of this study is to determine and compare the safety and efficacy of multiple broad area photodynamic therapy treatments with aminolevulinic acid (ALA-PDT) and vehicle (VEH-PDT) in subjects with moderate to severe facial acne vulgaris.
What is the current status of trial NCT00706433?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 266 participants. The study started on 2007-03. Estimated completion is 2008-07.
What conditions does trial NCT00706433 study?
This clinical trial studies the following conditions: Acne Vulgaris.
What interventions are being tested in trial NCT00706433?
The interventions under investigation include: aminolevulinic acid HCL (ALA) (DRUG), Vehicle (VEH) (OTHER).
Who is sponsoring clinical trial NCT00706433?
This trial is sponsored by DUSA Pharmaceuticals, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00706433 being conducted?
This trial has 14 study locations across Arkansas, California, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acne Vulgaris
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00706433's enrollment target sits among peer trials
266 25th of 67 higher than 43 of 67 other Acne Vulgaris trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acne Vulgaris trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Moderate to Severe Acne Vulgaris With Photodynamic Therapy in Adults
ACTIVE NOT RECRUITING · Phase 2
-
Dose Range Study of CD5789 in Acne Vulgaris
COMPLETED · Phase 2
-
An Evaluation of the Adrenal Suppression Potential and PK of CB-03-01 Cream in Pediatric Patients With Acne Vulgaris
COMPLETED · Phase 2
-
Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Patients With Skin Type V or IV With Acne Vulgaris
COMPLETED · Phase 2
-
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris
COMPLETED · Phase 2
-
A Clinical Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05098652 · 266 participants · NA
Coaching Dementia Caregivers to Master Care-Resistant Behavior
- NCT06088277 · 266 participants · NA
Texting to Reduce Human Immunodeficiency Virus (HIV) Risk
- NCT06261814 · 266 participants · Phase 2
Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors
- NCT06312124 · 266 participants · NA
A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia